$1.14
0.04[3.64%]
At close: Apr 26
$1.14
0[0.00%]
After Hours: 4:42PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
01/08/2024 | RIGL | Rigel Pharmaceuticals | Q4 | 2023 | — | — | — | $35.70M | $35.70M | $29.78M | Get Alert |
01/09/2023 | RIGL | Rigel Pharmaceuticals | Q4 | 2022 | — | — | — | $51.30M | $51.30M | $21.65M | Get Alert |
01/10/2022 | RIGL | Rigel Pharmaceuticals | Q4 | 2021 | — | — | — | $20.40M | $20.40M | $23.39M | Get Alert |
01/11/2021 | RIGL | Rigel Pharmaceuticals | Q4 | 2020 | — | — | — | $18.40M | $18.40M | $17.81M | Get Alert |
01/13/2020 | RIGL | Rigel Pharmaceuticals | Q4 | 2019 | — | — | — | $15.40M | $15.40M | $15.14M | Get Alert |
There have been no specific sales or earnings guidance reported for Rigel Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.